Apis Mellifica 6c label

Apis Mellifica 6c

Apis Mellifica 6c Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

If pregnant or breast feeding ask a health professional before use.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Water retention symptoms

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Apis Mellifica 6c Manufacturers

  • Paramesh Banerji Life Sciences Llc
    Apis Mellifica 6c | Patchwerx Labs, Inc.
    No Recall

    Apis Mellifica 6c | Patchwerx Labs, Inc.

    Apis Mellifica 6c | Patchwerx Labs, Inc.

    When Lidocaine Ointment 5% is used concomitantly with other products containing lidocaine, the total dose contributed by all formulations must be kept in mind.

    Adult

    A single application should not exceed 5 g of Lidocaine Ointment 5%, containing 250 mg of lidocaine base (equivalent chemically to approximately 300 mg of lidocaine hydrochloride). This is roughly equivalent to squeezing a six (6) inch length of ointment from the tube. In a 70 kg adult this dose equals 3.6 mg/kg (1.6 mg/lb) lidocaine base. No more than one-half tube or one-third of a jar, approximately 17-20 g of ointment or 850-1000 mg lidocaine base should be administered in any one day.

    Although the incidence of adverse effects with Lidocaine Ointment 5% is quite low, caution should be exercised, particularly when employing large amounts, since the incidence of adverse effects is directly proportional to the total dose of local anesthetic agent administered.